Fifth Lane Capital »

Sab Biotherapeutics shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $56k 15k 3.74

More positions owned by Fifth Lane Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Hologic Call Option (HOLX)
Renatus Tactical Acquis Shs Cl A (RTAC)
Avidity Biosciences Ord (RNA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Cantor Equity Partners Iv Shs Cl A (CEPF)
New Amer Acquisition I Corp Unit 99/99/9999 (NWAX.U)
Amazon Call Option (AMZN)
Cantor Equity Partners Ii Cl A Ord Shs (CEPT)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Futurecrest Acquisition Cl A Ord Shs (FCRS)
Btc Dev Corp Ord Shs Cl A (BDCI)
UnitedHealth (UNH)

View all positions for Fifth Lane Capital

Top funds holding Sab Biotherapeutics

Vivo Capital
RA Capital Management
Commodore Capital
Woodline Partners
Sessa Capital IM
Vanguard Group
BVF
Propel Bio Management
Leucadia National Corporation
HB Wealth Management
Marshall Wace
Simplify Asset Management
AWM Investment Company
Stempoint Capital
Geode Capital Management

View all funds holding Sab Biotherapeutics